Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New phase I trial studies NPI-0052 in multiple myeloma

April 25, 2007

Roche files Avastin and Xeloda submissions in Europe

April 25, 2007

FDA accepts Xcytrin NDA for filing

April 25, 2007

Nippon Shinyaku discontinues development of NS-9

April 25, 2007

In vivo antitumor activity of novel anti-IGF-1R antibody reported by Schering-Plough

April 25, 2007

GGTase I inhibitor and prodrug profiled at AACR annual meeting

April 25, 2007

Enrollment completed in phase III study of Cerepro

April 25, 2007

Pharmion advances oral azacitidine in phase I

April 25, 2007

SuperGen to sell mitomycin and paclitaxel to Intas

April 24, 2007

MKC-1 disrupts microtubules and multiple survival pathways in hematological cancers

April 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...